Spectrum’s Zevalin Still Living In Rituxan’s Shadow, FDA Advertising Letter Shows

FDA citations of Rituxan comparisons in a promotion for Zevalin throw added salt on old wounds for drug that has taken backseat to Rituxan’s blockbuster story.